NASDAQ: SGMT Sagimet Biosciences Inc. 8-K

Sagimet raises $164.5M in public offering to fund Phase 3 acne trial

Filed April 28, 2026 · Period ending April 27, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SGMT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 5:32 PM